FDA Greenlights Kythera’s Kybella
In a much anticipated approval, the FDA has given its nod to Kythera's Kybella to treat double chins.
In a much anticipated approval, the FDA has given its nod to Kythera's Kybella to treat double chins.
The phase IV trial evaluated outcomes of Sculptra plus Restylane Lyft or Contour in patients with facial volume loss due to weight loss medications.